Global Allergy Immunotherapy Market: Size, Trends & Forecasts (2016-2020) - Daedal Research

DELHI, India - Dec. 2, 2016 - PRLog -- The report titled "Global Allergy Immunotherapy Market: Size, Trends & Forecasts (2016-2020)", provides an in-depth analysis of the global allergy immunotherapy market by value, by methods of administration, by region, etc.

The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global allergy immunotherapy market has also been forecasted for the period 2016-2020, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

The key players of the allergy immunotherapy market ALK-Abello, Allergy Therapeutics, Merck Group and Stallergenes, who are also profiled with their financial information and respective business strategies.

Country Coverage

Europe
Rest of the World
US

Company Coverage

Allergy Therapeutics plc
ALK-Abello
Merck Group
Stallergenes

Executive Summary

Allergy refers to a condition in which the immune system abnormally reacts to the foreign substance. The foreign substance could be in the form of particular food, pollen, pets, metals, fur, dust, etc. to which the body becomes hypersensitive when comes into contact. The foreign substance that triggers the hypersensitive response in the body is known as an allergen. Generally, most substances that cause allergies are normally harmless to the human body and have no effect on the vast majority of people that are not allergic. Allergy is not a disease, it is a mere over-reaction of body to the foreign substance that is not harmful. To diagnose an allergy skin test, blood test and allergy component tests are undertaken. Allergies are generally seasonal and perennial in nature.

The global allergy immunotherapy market has increased at a significant CAGR during the years 2009-2015 and projections are made that the market would rise in the next four years i.e. 2016-2020 tremendously. The allergy immunotherapy market is expected to increase due to growth in healthcare expenditure, rising incidence of chronic diseases and increasing global pollution, etc. Yet the market faces some challenges such as, lack of treatment awareness, lack of investor confidence, anaphylaxia, huge treatment costs, etc.

List of Figures:

Figure 1: Mechanism of Allergy

Figure 2: Diagnosis of Allergy

Figure 3: Nature of Allergy

Figure 4: Types of Allergy

Figure 5: Types of Allergens

Figure 6: Types of Immunotherapy

Figure 7: Immunotherapy by Methods of Administration

Figure 8: Global Allergy Immunotherapy Market by Value; 2009-2015 (US$ Billion)

Figure 9: Global Allergy Immunotherapy Market by Value; 2016-2020 (US$ Billion)

Figure 10: Global Allergy Immunotherapy Market by Geography; 2015 (Percentage, %)

Figure 11: Global Allergy Immunotherapy Market by Method of Administration; 2015 (Percentage, %)

Figure 12: Global Subcutaneous Immunotherapy Market by Value; 2009-2015 (US$ Million)

Figure 13: Global Subcutaneous Immunotherapy Market by Value; 2016-2020 (US$ Million)

Figure 14: Global Sublingual Immunotherapy Solution Market by Value; 2009-2015 (US$ Million)

Figure 15: Global Sublingual Immunotherapy Solution Market by Value; 2016-2020 (US$ Million)

Figure 16: Global Sublingual Immunotherapy-Tablet Market by Value; 2009-2015 (US$ Million)

Figure 17: Global Sublingual Immunotherapy-Tablet Market by Value; 2016-2020 (US$ Million)

Figure 18: Europe Allergy Immunotherapy Market by Value; 2009-2015 (US$ Million)

Figure 19: Europe Allergy Immunotherapy Market by Method of Administration; 2014 (Percentage, %)

Figure 20: Europe Allergy Immunotherapy Market by Regional Distribution; 2014 (Percentage, %)

Figure 21: Rest of the World Allergy Immunotherapy Market by Value; 2009-2015 (US$ Million)

Figure 22: US Allergy Immunotherapy Market by Value; 2009-2015 (US$ Million)

Figure 23: US Allergy Immunotherapy Market by Method of Administration; 2014 (Percentage, %)

Figure 24: Global Population with Chronic Diseases; 2009-2014 (Million)

Figure 25: Global Healthcare Expenditure; 2009-2014 (US$ Trillion)

Figure 26: Global Greenhouse Gas Emissions by Gases; 2014 (Percentage, %)

Figure 27: Global Allergy Immunotherapy Market Players by Share; 2014 Percentage (%)

Figure 28: Europe Allergy Immunotherapy Market Players by Share; 2014 (Percentage, %)

Figure 29: US Allergy Immunotherapy Market Players by Share; 2014 (Percentage, %)

Figure 30: Allergy Therapeutics Revenue; 2012-2016 (US$ Million)

Figure 31: Allergy Therapeutics Revenue by Region; 2016

Figure 32: ALK-Abello Revenue; 2011-2015 (US$ Million)

Figure 33: ALK-Abello Revenue by Product Line; 2015

Figure 34: Merck Group Net Sales; 2011-2015 (US$ Billion)

Figure 35: Merck Group Net Sales by Business Sector; 2015

Figure 36: Stallergenes Product Portfolio

Figure 37: Stallergenes Net Sales; 2011-2015 (US$ Million)

Figure 38: Stallergenes Net Sales by Product Type; 2015

Table 1: Length and Inconvenience Associated with Treatments

Table 2: Evaluation of Current Allergy Treatments

Table 3: Circassia Ultra-Short Course Subcutaneous Immunotherapy Segment

Table 4: Global Allergy Immunotherapy Market Players by Product Development Stage

Table 5: Global Allergy Immunotherapy Market Players by Treatment Course Duration

Table 6: Global Allergy Immunotherapy Market Players by Subcutaneous Immunotherapy Products for Grass Pollen Rhinitis

For further details, kindly visit :

http://www.daedal-research.com//global-allergy-immunotherapy-market-size-trends-forecasts-2016-2020 (http://www.daedal-research.com/global-allergy-immunothera...)

Rajeev Kumar

(Business Development Manager)

Address:  36 SFS Flats

Paschim Vihar

New Delhi-110063

Mobile: +91-9811715635

Tel: +91-120-4553017

Mail ID - info@daedal-research.com